US Philly Fed New Orders (Aug) 30.1 (Prev. 37.0)
Newsquawk Staff ·
US Philly Fed New Orders (Aug) 30.1 (Prev. 37.0)
What it means
A drop in the new orders component from a still-elevated level is the classic pattern late in a regional manufacturing upswing: the subindex remains firmly in expansion territory, so the print reads as deceleration rather than contraction. Philly Fed is one of the earlier regional factory surveys in the monthly sequence, and its orders and employment components have historically been treated as a soft lead on the national ISM rather than a market mover in its own right; headline index misses tend to matter more than single-component slippage unless the components corroborate each other. The distinction worth drawing is between orders cooling from strength, which is consistent with normalisation, and orders converging toward the breakeven line alongside falling shipments and employment, which is the configuration that has preceded genuine manufacturing downturns. The follow-ons are the remaining regional Fed surveys and the ISM, where confirmation across districts has historically been the tell; a lone soft component in one district has rarely repriced the front end on its own. The Fed tag is relevant only insofar as sustained order-book erosion feeds the growth side of the reaction function, and a single month's subindex does not meet that bar.
- [MARKET ANALYSIS] DXY holds steady; AUD benefits after hawkish commentary from RBA's Hauser, whilst GBP digests UK CPI
- EUROPEAN OPEN: SPCX up after results, TSLA merger talks; SMCI surges on raised outlook; ADS GY beat and raise; DB1 GY beat and raise; CA FP cuts outlook on weak French demand; Belgium pressure to sell BNP FP stake; EQT SS advances on QIA GY
- Newsquawk Daily European Opening News - 21st October 2026
- [MARKET ANALYSIS] Complex capped by energy; T-notes dip after Tuesday's bull-flattening
- [MARKET ANALYSIS] USD marginally firmer; AUD outperforms; price action quiet elsewhere
Related headlines
- [MARKET ANALYSIS] APAC stocks mostly firmer on AI after-hours strength; KOSPI leads10 hours ago
- PBoC sets USD/CNY midpoint at 6.7172 vs exp. 6.6779 (prev. 6.7200) 10 hours ago
- PBoC is expected to set USD/CNY mid-point at 6.6779 (Prev. 6.7200)11 hours ago
- Abbott Laboratories (ABT) Q3 2026 (USD): Adj. EPS 1.42 (exp. 1.42), Revenue 13.0bln (exp. 12.99bln)25 min ago
- Abbott (ABT) announced its intention to separate its Nutrition business into an independent, publicly traded company with approximately USD 8.5bln in annual sales and a portfolio of brands30 min ago
- CME Group Inc. (CME) Q3 2026 (USD): Adj. EPS 3.02 (exp. 2.98), Revenue 1.7bln (exp. 1.71bln)56 min ago
- Moody's (MCO) Q3 2026 (USD): Adj. EPS 4.14 (exp. 4.24), Revenue 2.023bln (exp. 2.07bln)56 min ago
- Philip Morris International Inc. (PM) Q3 2026 (USD): Adj. EPS 2.36 (exp. 2.29), Net revenue 11.4bln (exp. 11.32bln)57 min ago
- US President Trump posts "Numerous people, who requested that sanctions be immediately imposed on Russia, have called to apologize... they didn’t know that he was negotiating the release of Stephen Hubbard"1 hour ago
- Ukrainian President Zelensky says trilateral meeting at minimum is necessary, according to Fox News; Important that Ukraine to be in any meeting and would also be better with Europeans; any deal would require a referendum1 hour ago
- AT&T Inc (T) Q3 2026 (USD) adj. EPS 0.65 (exp. 0.60), Revenue 32.2bln (exp. 31.69bln), Current FY EPS c. 2.40 (exp. 2.34)1 hour ago
- Russia's Kremlin says they will look at the US' proposal, but it is largely dependent on Ukraine. Adds, conversation between Russian President Putin and US President Trump will be both long and serious1 hour ago
- US President Trump's administration is reportedly to evaluate whether additional loans from the heating oil reserve should occur, sources reports; Energy Department to loan as much as one third of the 1mln barrel northeast heating oil reserve1 hour ago
- Danaher (DHR) Q3 2026 (USD): Adj. EPS 2.11 (exp. 1.92), Revenue 6.6bln (exp. 6.56bln); FY Outlook Adj. EPS 8.57-8.62 (exp. 8.50, prev. guided 8.45-8.60)1 hour ago
- Elevance Health (ELV) Q3 2026 (USD): adj. EPS 6.99 (exp. 4.70), Revenue 50.4bln (exp. 49.29bln); raises FY guidance1 hour ago